MeadowBrook Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9K Hold
250
0.05% 177
2026
Q1
$54.4K Hold
250
0.05% 181
2025
Q4
$57.1K Hold
250
0.05% 185
2025
Q3
$57.9K Hold
250
0.05% 179
2025
Q2
$46.4K Hold
250
0.04% 191
2025
Q1
$52.4K Sell
250
-174
-41% -$33.8K 0.05% 174
2024
Q4
$75.3K Hold
424
0.07% 162
2024
Q3
$83.7K Sell
424
-377
-47% -$70.4K 0.08% 147
2024
Q2
$137K Hold
801
0.13% 126
2024
Q1
$146K Sell
801
-150
-16% -$25.9K 0.14% 127
2023
Q4
$147K Buy
+951
New +$139K 0.14% 125

Other funds holding ABBV

MeadowBrook Investment Advisors's ABBV Position: Q2 2026 in Review

MeadowBrook Investment Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 250 shares worth $62.9K. The position accounts for 0.05% of the portfolio, ranked #177.

MeadowBrook Investment Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $147K in Q4 2023. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MeadowBrook Investment Advisors held 250 shares of AbbVie worth $62.9K as of Q2 2026.
  • MeadowBrook Investment Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.05% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #177 holding.
  • MeadowBrook Investment Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's AbbVie position peaked at $147K in Q4 2023.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.